Literature DB >> 5134301

Radioprotective effect of isopentenyladenosine in mice.

N Prasad, S C Bushong, H L Barton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5134301     DOI: 10.1007/BF02136721

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  On the mechanism of radiation protection by cysteamine: an invstigation by means of electron spin resonance.

Authors:  M G ORMEROD; P ALEXANDER
Journal:  Radiat Res       Date:  1963-04       Impact factor: 2.841

2.  Structure of a mammalian serine tRNA.

Authors:  M Staehelin; H Rogg; B C Baguley; T Ginsberg; W Wehrli
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

3.  Protection against x-irradiation employing cysteamine derivatives in tissue culture and in mice.

Authors:  O Vos; G A Grant; L Budke
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1970

4.  Radioprotective effect of phytohemagglutinin in mice.

Authors:  S Stefani
Journal:  Experientia       Date:  1970-01-15

5.  N6-(delta-2-isopentenyl) adenosine--effects upon nucleic acid synthesis in lymphocytes in vitro and the development of immunologic hypersensitivity in vivo.

Authors:  B Hacker; T L Feldbush
Journal:  Biochem Pharmacol       Date:  1969-04       Impact factor: 5.858

6.  N-6-(delta-3-isopentenyl) adenosine. A component of the transfer ribonucleic acid of yeast and of mammalian tissue, methods of isolation, and characterization.

Authors:  M J Robins; R H Hall; R Thedford
Journal:  Biochemistry       Date:  1967-06       Impact factor: 3.162

7.  Selective modification of yeast seryl-t-RNA and its effect on the acceptance and binding functions.

Authors:  F Fittler; R H Hall
Journal:  Biochem Biophys Res Commun       Date:  1966-11-22       Impact factor: 3.575

8.  Isopentenyladenosine stimulates and inhibits mitosis of human lymphocytes treated with phytohemagglutinin.

Authors:  R C Gallo; J Whang-Peng; S Perry
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.